LFCRHealthcareMicro-Cap

LIFECORE BIOMEDICAL, INC. \DE\ Insider Trading Activity

Every SEC Form 4 insider transaction reported for LIFECORE BIOMEDICAL, INC. \DE\ (LFCR), sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are LFCR insiders buying or selling?

LIFECORE BIOMEDICAL, INC. \DE\ insiders reported 47 open-market buys ($27.0M) and 5 sells ($10.0M) across 52 Form 4 filings — a net buying position of $17.0M.

Source: SEC EDGAR Form 4

Key Statistics (as of May 29, 2025)

Total Form 4 filings
52
SEC EDGAR
Insider filers
17
Insider buys (47)
$27.0M
Insider sells (5)
$10.0M

Insider sentiment

Net buying

Net insider flow of $17.0M in net buying.

Recent LFCR insider transactions

DateInsiderRoleTypeSharesPriceValue
May 29, 2025Aron R. English10% OwnerSale1.4M$6.59$9.1M
May 16, 2025Aron R. English10% OwnerSale12.3K$7.00$86.4K
May 12, 2025Aron R. English10% OwnerSale51.5K$7.03$362.0K
May 8, 2025Aron R. English10% OwnerSale41.1K$7.05$289.9K
Jan 8, 2025Paul JosephsChief Executive OfficerPurchase17.0K$5.74$97.6K
Oct 8, 2024Nelson Obus10% OwnerPurchase292.7K$4.10$1.2M
Oct 7, 2024Christopher S KiperDirector, 10% OwnerPurchase1.5M$4.10$6.0M
Jan 18, 2023Nelson Obus10% OwnerPurchase627.7K$7.97$5.0M
Oct 26, 2022Nelson Obus10% OwnerPurchase250.0K$8.09$2.0M
Jan 14, 2022Nelson Obus10% OwnerPurchase387.4K$10.41$4.0M
Jan 14, 2022Joshua SchechterDirectorPurchase10.0K$10.39$103.9K
Apr 22, 2021Patrick D WalshDirectorPurchase10.0K$11.26$112.6K
Apr 21, 2021Timothy P BurgessSenior VP of Supply ChainPurchase5.0K$9.99$50.4K
Apr 20, 2021John D MorbergChief Financial OfficerPurchase2.0K$11.05$22.1K
Apr 19, 2021John D MorbergChief Financial OfficerPurchase2.0K$11.08$22.2K
Apr 16, 2021John D MorbergChief Financial OfficerPurchase2.0K$10.98$22.0K
Apr 15, 2021Albert D. BollesChief Executive OfficerPurchase9.0K$10.61$95.5K
Apr 15, 2021James G HallVice PresidentPurchase10.0K$10.62$106.2K
Apr 15, 2021John D MorbergChief Financial OfficerPurchase2.0K$10.64$21.3K
Apr 15, 2021Nelson Obus10% OwnerPurchase240.6K$10.02$2.4M
Apr 14, 2021Nelson Obus10% OwnerPurchase240.6K$10.02$2.4M
Apr 13, 2021John D MorbergChief Financial OfficerPurchase2.0K$10.18$20.4K
Feb 12, 2021John D MorbergChief Financial OfficerPurchase1.4K$11.88$16.6K
Feb 11, 2021John D MorbergChief Financial OfficerPurchase2.0K$11.64$23.3K
Feb 10, 2021John D MorbergChief Financial OfficerPurchase2.0K$12.06$24.1K

Showing the 25 most recent of 52 Form 4 filings for LIFECORE BIOMEDICAL, INC. \DE\.

Most active LFCR insiders

  • Nelson Obus16 filings
  • John D Morberg10 filings
  • Nelson Obus6 filings
  • Aron R. English4 filings
  • Albert D. Bolles3 filings

Ask anything about LFCR insider activity

Use Trabud's AI agent to query LIFECORE BIOMEDICAL, INC. \DE\'s Form 4 history in plain English — "Show me LFCR CEO purchases this year" or compare it against any other ticker.

Open the AI agent

LFCR insider trading FAQ

Are LIFECORE BIOMEDICAL, INC. \DE\ insiders buying or selling?

Across 52 SEC Form 4 filings, LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) insiders reported 47 open-market purchases totaling $27.0M and 5 sales totaling $10.0M. That is a net buying position of $17.0M.

How many insiders trade LFCR stock?

17 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for LIFECORE BIOMEDICAL, INC. \DE\. The most recent filing was accepted on May 29, 2025.

Where does Trabud get LFCR insider trading data?

All LFCR insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Looking for another company? Browse all tracked companies.

Related Content